Driven by innovation, research, and a deep commitment to social responsibility, Pharmalat has grown from a small, family-run ...

K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.

Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...

Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

Traditional approaches to benchmarking brand performance have struggled to keep pace with industry dynamics. While individual ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

The National Agency for Food and Drug Administration and Control, NAFDAC, has gone digital in its efforts to rid the country ...